These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29290626)

  • 1. TET2 Loss Dysregulates the Behavior of Bone Marrow Mesenchymal Stromal Cells and Accelerates Tet2
    Li R; Zhou Y; Cao Z; Liu L; Wang J; Chen Z; Xing W; Chen S; Bai J; Yuan W; Cheng T; Xu M; Yang FC; Zhao Z
    Stem Cell Reports; 2018 Jan; 10(1):166-179. PubMed ID: 29290626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies.
    Li Z; Cai X; Cai CL; Wang J; Zhang W; Petersen BE; Yang FC; Xu M
    Blood; 2011 Oct; 118(17):4509-18. PubMed ID: 21803851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-catalytic Roles of Tet2 Are Essential to Regulate Hematopoietic Stem and Progenitor Cell Homeostasis.
    Ito K; Lee J; Chrysanthou S; Zhao Y; Josephs K; Sato H; Teruya-Feldstein J; Zheng D; Dawlaty MM; Ito K
    Cell Rep; 2019 Sep; 28(10):2480-2490.e4. PubMed ID: 31484061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.
    Moran-Crusio K; Reavie L; Shih A; Abdel-Wahab O; Ndiaye-Lobry D; Lobry C; Figueroa ME; Vasanthakumar A; Patel J; Zhao X; Perna F; Pandey S; Madzo J; Song C; Dai Q; He C; Ibrahim S; Beran M; Zavadil J; Nimer SD; Melnick A; Godley LA; Aifantis I; Levine RL
    Cancer Cell; 2011 Jul; 20(1):11-24. PubMed ID: 21723200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells.
    Pan F; Wingo TS; Zhao Z; Gao R; Makishima H; Qu G; Lin L; Yu M; Ortega JR; Wang J; Nazha A; Chen L; Yao B; Liu C; Chen S; Weeks O; Ni H; Phillips BL; Huang S; Wang J; He C; Li GM; Radivoyevitch T; Aifantis I; Maciejewski JP; Yang FC; Jin P; Xu M
    Nat Commun; 2017 Apr; 8():15102. PubMed ID: 28440315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific functions of TET1 and TET2 in regulating mesenchymal cell lineage determination.
    Cakouros D; Hemming S; Gronthos K; Liu R; Zannettino A; Shi S; Gronthos S
    Epigenetics Chromatin; 2019 Jan; 12(1):3. PubMed ID: 30606231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of miR-199a-5p in osteoblast differentiation by targeting TET2.
    Qi XB; Jia B; Wang W; Xu GH; Guo JC; Li X; Liu JN
    Gene; 2020 Feb; 726():144193. PubMed ID: 31669647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional analysis of TET2 using a knockdown mouse model].
    Shide K; Kameda T; Shimoda K
    Rinsho Ketsueki; 2015 Jun; 56(6):657-65. PubMed ID: 26256876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function.
    Sun J; He X; Zhu Y; Ding Z; Dong H; Feng Y; Du J; Wang H; Wu X; Zhang L; Yu X; Lin A; McDonald T; Zhao D; Wu H; Hua WK; Zhang B; Feng L; Tohyama K; Bhatia R; Oberdoerffer P; Chung YJ; Aplan PD; Boultwood J; Pellagatti A; Khaled S; Kortylewski M; Pichiorri F; Kuo YH; Carlesso N; Marcucci G; Jin H; Li L
    Cell Stem Cell; 2018 Sep; 23(3):355-369.e9. PubMed ID: 30146412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis.
    Cheng J; Guo S; Chen S; Mastriano SJ; Liu C; D'Alessio AC; Hysolli E; Guo Y; Yao H; Megyola CM; Li D; Liu J; Pan W; Roden CA; Zhou XL; Heydari K; Chen J; Park IH; Ding Y; Zhang Y; Lu J
    Cell Rep; 2013 Oct; 5(2):471-81. PubMed ID: 24120864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate hematopoietic stem and progenitor cells.
    Jin X; Qin T; Zhao M; Bailey N; Liu L; Yang K; Ng V; Higashimoto T; Coolon R; Ney G; Figueroa ME; Li Q
    Blood Adv; 2018 Jun; 2(11):1259-1271. PubMed ID: 29866713
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Kunimoto H; McKenney AS; Meydan C; Shank K; Nazir A; Rapaport F; Durham B; Garrett-Bakelman FE; Pronier E; Shih AH; Melnick A; Chaudhuri J; Levine RL
    Blood; 2017 Mar; 129(13):1779-1790. PubMed ID: 28077417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TET2 interactors and their links to hematological malignancies.
    Pan F; Weeks O; Yang FC; Xu M
    IUBMB Life; 2015 Jun; 67(6):438-45. PubMed ID: 26099018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation.
    Song SJ; Ito K; Ala U; Kats L; Webster K; Sun SM; Jongen-Lavrencic M; Manova-Todorova K; Teruya-Feldstein J; Avigan DE; Delwel R; Pandolfi PP
    Cell Stem Cell; 2013 Jul; 13(1):87-101. PubMed ID: 23827711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Positive Effect of TET2 on the Osteogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells.
    Feng L; Zhou J; Xia B; Tian BF
    Cell Reprogram; 2020 Feb; 22(1):3-13. PubMed ID: 31829736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt7b-induced Sox11 functions enhance self-renewal and osteogenic commitment of bone marrow mesenchymal stem cells.
    Yu F; Wu F; Li F; Liao X; Wang Y; Li X; Wang C; Shi Y; Ye L
    Stem Cells; 2020 Aug; 38(8):1020-1033. PubMed ID: 32346881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis.
    Cai Z; Kotzin JJ; Ramdas B; Chen S; Nelanuthala S; Palam LR; Pandey R; Mali RS; Liu Y; Kelley MR; Sandusky G; Mohseni M; Williams A; Henao-Mejia J; Kapur R
    Cell Stem Cell; 2018 Dec; 23(6):833-849.e5. PubMed ID: 30526882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tet2 regulates the function of mesenchymal stem cells].
    Gu J; Wang Y; Gao J; Yuan S; Chu Y; Li Y; Yuan W; Wang X
    Sheng Wu Gong Cheng Xue Bao; 2019 Jan; 35(1):142-149. PubMed ID: 30756543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic TNF in the aging microenvironment exacerbates Tet2 loss-of-function myeloid expansion.
    Quin C; DeJong EN; McNaughton AJM; Buttigieg MM; Basrai S; Abelson S; Larché MJ; Rauh MJ; Bowdish DME
    Blood Adv; 2024 Aug; 8(15):4169-4180. PubMed ID: 38924753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The catalytic activity of TET2 is essential for its myeloid malignancy-suppressive function in hematopoietic stem/progenitor cells.
    Zhao Z; Chen S; Zhu X; Pan F; Li R; Zhou Y; Yuan W; Ni H; Yang FC; Xu M
    Leukemia; 2016 Aug; 30(8):1784-1788. PubMed ID: 27003514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.